Moxifloxacin is a broad-spectrum fluoroquinolone antibiotic used primarily to treat bacterial infections such as respiratory tract infections, skin infections, and intra-abdominal infections. It works by inhibiting bacterial DNA gyrase and topoisomerase IV, enzymes essential for DNA replication and repair. Ensuring the pharmaceutical purity of Moxifloxacin is vital for therapeutic effectiveness, patient safety, and adherence to regulatory standards. Impurity profiling is crucial to detect and control undesirable substances that may arise during synthesis, storage, or degradation. Here are some of its known impurities listed below.
Showing 1 - 3 of 3 products
Catalogue No : MOXI-OCL-002
CAS No : 154093-72-8
In Stock
Synonyms
1-Cyclopropyl-6,7-difluoro-1,4-dihydro-8-hydroxy-4-oxo-3-quinoline carboxylic acid
1-Cyclopropyl-6,7-difluoro-1,4-dihydro-8-hydroxy-4-oxo-3-quinoline carboxylic acid
Catalogue No : MOXI-OCL-003
CAS No : 452092-31-8
In Stock
Synonyms
1-Cyclopropyl-6,7-difluoro-1,4-dihydro-8-hydroxy-4-oxo-3-quinoline carboxylic acid ethyl ester
1-Cyclopropyl-6,7-difluoro-1,4-dihydro-8-hydroxy-4-oxo-3-quinoline carboxylic acid ethyl ester
Catalogue No : MOXI-OCL-001
CAS No : 186826-86-8
In Stock
Synonyms
1-Cyclopropyl-6-fluoro-8-methoxy-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-1,4-dihydroquinoline-3-carboxylic acid hydrochloride
1-Cyclopropyl-6-fluoro-8-methoxy-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-1,4-dihydroquinoline-3-carboxylic acid hydrochloride